The national law firm of Parker Waichman LLP has filed three lawsuits in the Supreme Court of New York, County of New York against Bristol-Myers Squibb and Sanofi-Aventis alleging that the blood thinner Plavix caused the plaintiffs to suffer cerebral hemorrhaging.
The lawsuits were filed on behalf of a man from Hawaii who started taking Plavix in October 2009 and suffered a cerebral hemorrhage in June 2010; a woman from Kansas who started Plavix in August 2008 and developed a cerebral hemorrhage in June 2010; and a woman from Louisiana who started Plavix in 2000 and suffered a cerebral hemorrhage in 2011.
According to the lawsuits, the defendants failed to properly test the blood thinner Plavix while marketing the drug as a safe and effective alternative to other blood thinners for the prevention of blood clots, heart attack and stroke. The defendants also promoted a dual therapy of Plavix and Aspirin as a safe and effective treatment, while the lawsuits say the FDA had warned Bristol-Myers Squibb and Sanofi-Aventis that the dual therapy was not more effective at preventing heart attack, stroke, or even death from cardiovascular causes then Aspirin alone. In fact, the plaintiffs claim that Plavix users have an increased risk of heart attack, stroke, blood disorders, internal bleeding, and death.
The three lawsuits allege that the blood thinner Plavix causes severe and permanent injuries, physical impairment and disfigurement, physical pain and suffering , mental pain and suffering, loss of enjoyment of life, and past, present, and future medical expenses.